ETFs
U
UTHR
United Therapeutics Corp.
581.69
+15.99+2.83%After Hours: 585.80 +4.11 +0.71%16:26 04/08 EDT
OPEN/PREV CLOSE575.00/577.58
TODAY RANGE573.34-581.92
VOL4
MARKET CAP25.44B
52 WEEK RANGE272.12-607.89
AVG VOL (3M)516.95K
% TURNOVER1.08%
TURNOVER0
P/E (TTM)20.83
% RANGE1.44%
EPS(TTM)27.86
P/E(FORWARD)20.08
P/B3.570
BVPS162.60
DIVIDEND--
P/S7.96
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP24.89B
SHARES OUTSTANDING43.83M
NEXT EARNINGS04/28-05/04
FREE FLOAT42.87M
LOT SIZE1
EX-DATE09/23/2009
News
Press Releases
Financial Reports
Profile
Simply Wall St·23h ago
How FDA RMAT Status For Bioengineered Liver Device At United Therapeutics (UTHR) Has Changed Its Investment Story
Simply Wall St·4d ago
A Look At United Therapeutics (UTHR) Valuation After RMAT Win And Tyvaso Phase 3 Success
Simply Wall St·6d ago
Is It Too Late To Consider United Therapeutics (UTHR) After A 106% One-Year Surge?
TipRanks·6d ago
Morgan Stanley Remains a Hold on United Therapeutics (UTHR)
Same Industry
Name/Symbol
Change%
Price